Dana Farber - Harvard

Boston, Massachusetts

0 studies enrolling now · 2 studies all time

What they study most

Solid Cancers, Solid Tumors

Studies at this site

• A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors — Completed
• A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors — Completed